Fig. 2From: New immunotherapy approaches for colorectal cancer: focusing on CAR-T cell, BiTE, and oncolytic virusesBispecific antibodies (BiTE) comprise two flexibly linked single-chain antibodies, one binding to the surface antigen on the target cell and the other to CD3 on T cells. Some new BiTEs against CEA, EGFR, and Cd1d can be immunotherapy strategiesBack to article page